435 related articles for article (PubMed ID: 19713461)
1. Acute graft-versus-host disease: from the bench to the bedside.
Socié G; Blazar BR
Blood; 2009 Nov; 114(20):4327-36. PubMed ID: 19713461
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic skin graft-versus-host disease--pathophysiological aspects.
Socié G; Peffault de Latour R; Bouziz JD; Rybojad M
Curr Probl Dermatol; 2012; 43():91-100. PubMed ID: 22377923
[TBL] [Abstract][Full Text] [Related]
3. Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease.
Socié G; Kean LS; Zeiser R; Blazar BR
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 34101618
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of allogeneic hematopoietic stem cell transplantation.
Welniak LA; Blazar BR; Murphy WJ
Annu Rev Immunol; 2007; 25():139-70. PubMed ID: 17129175
[TBL] [Abstract][Full Text] [Related]
5. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?
Zeiser R; Blazar BR
Blood; 2016 Jun; 127(25):3117-26. PubMed ID: 26994149
[TBL] [Abstract][Full Text] [Related]
6. The cytokine modulation of acute graft-versus-host disease.
Ferrara JL
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S13-5. PubMed ID: 9712485
[TBL] [Abstract][Full Text] [Related]
7. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Duran-Struuck R; Reddy P
Transplantation; 2008 Feb; 85(3):303-8. PubMed ID: 18301323
[TBL] [Abstract][Full Text] [Related]
8. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease.
Chang YJ; Zhao XY; Huang XJ
Front Immunol; 2018; 9():3041. PubMed ID: 30619371
[TBL] [Abstract][Full Text] [Related]
9. Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Fu J; Heinrichs J; Yu XZ
Arch Immunol Ther Exp (Warsz); 2014 Aug; 62(4):277-301. PubMed ID: 24699629
[TBL] [Abstract][Full Text] [Related]
10. Advances in understanding the pathogenesis of graft-versus-host disease.
Magenau J; Runaas L; Reddy P
Br J Haematol; 2016 Apr; 173(2):190-205. PubMed ID: 27019012
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL; Bloom EJ
Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease.
Li M; Sun K; Welniak LA; Murphy WJ
Expert Opin Pharmacother; 2008 Sep; 9(13):2305-16. PubMed ID: 18710355
[TBL] [Abstract][Full Text] [Related]
13. New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects.
Deeg HJ
Int J Hematol; 2003 Jan; 77(1):15-21. PubMed ID: 12568295
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiologic mechanisms of acute graft-vs.-host disease.
Ferrara JL; Levy R; Chao NJ
Biol Blood Marrow Transplant; 1999; 5(6):347-56. PubMed ID: 10595812
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of graft-versus-host disease.
Ferrara JL; Reddy P
Semin Hematol; 2006 Jan; 43(1):3-10. PubMed ID: 16412784
[TBL] [Abstract][Full Text] [Related]
16. Acute Graft-versus-Host Disease: Novel Biological Insights.
Teshima T; Reddy P; Zeiser R
Biol Blood Marrow Transplant; 2016 Jan; 22(1):11-6. PubMed ID: 26453971
[TBL] [Abstract][Full Text] [Related]
17. Advances in understanding the pathogenesis of graft-versus-host disease.
Zeiser R
Br J Haematol; 2019 Dec; 187(5):563-572. PubMed ID: 31588560
[TBL] [Abstract][Full Text] [Related]
18. Acute graft-versus-host disease.
Bolaños-Meade J; Vogelsang GB
Clin Adv Hematol Oncol; 2004 Oct; 2(10):672-82. PubMed ID: 16163254
[TBL] [Abstract][Full Text] [Related]
19. Progress and prospects: graft-versus-host disease.
Mastaglio S; Stanghellini MT; Bordignon C; Bondanza A; Ciceri F; Bonini C
Gene Ther; 2010 Nov; 17(11):1309-17. PubMed ID: 20508597
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease.
Koenecke C; Krueger A
Front Immunol; 2018; 9():992. PubMed ID: 29867969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]